Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1986-3-21
|
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0098-7484
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
255
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1174-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:otherAbstract |
KIE: The author raises the question of whether physicians should disclose the stakes they have as researchers in persuading their patients to participate in clinical trials. In the course of giving informed consent, patients are rarely told that their doctors may have strong financial and professional interests in recruiting them as subjects, that pharmaceutical companies and the National Institutes of Health pay research centers and physicians well for completed patient studies, and that professional advancement and distinction depend on the amount of research done. Spiro believes controlled clinical trials are valuable, but argues that full disclosure of the benefits that physicians expect to achieve from their patients' willingness to serve as subjects will enhance the latters' freedom to decide on participation.
|
pubmed:meshHeading |
pubmed-meshheading:3945039-Clinical Trials as Topic,
pubmed-meshheading:3945039-Disclosure,
pubmed-meshheading:3945039-Humans,
pubmed-meshheading:3945039-Informed Consent,
pubmed-meshheading:3945039-Research Subjects,
pubmed-meshheading:3945039-Research Support as Topic,
pubmed-meshheading:3945039-Truth Disclosure,
pubmed-meshheading:3945039-United States
|
pubmed:year |
1986
|
pubmed:articleTitle |
Mammon and medicine. The rewards of clinical trials.
|
pubmed:publicationType |
Journal Article
|